According to Foresight News, cryptocurrency derivatives exchange Bitnomial has announced the completion of a $25 million funding round, led by Ripple Labs. Ripple's CEO, Brad Garlinghouse, will join Bitnomial's board of directors as part of this investment.
In addition to the funding announcement, Bitnomial revealed plans to launch its new U.S. perpetual futures trading platform, Botanical, which is currently in closed beta testing. This development marks a significant step for Bitnomial as it aims to expand its offerings in the cryptocurrency derivatives market.
